Drug Profile
Lactobacilli based inflammatory therapy - Symbigene
Alternative Names: TricolLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Symbigene
- Class Contraceptives; Probiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases; Rheumatoid arthritis
Most Recent Events
- 26 Jul 2004 Preclinical trials in Inflammatory bowel disease in USA (PO)
- 26 Jul 2004 Preclinical trials in Rheumatoid arthritis in USA (PO)